Editorial - Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States
BERKELEY, CA (UroToday.com) - A genetic rearrangement with fusion of the TMPRSS2 prostate-specific gene with the ERG transcription factor is commonly found in prostate cancer (CaP) and has oncogenic potential.
 | Written by Christopher P. Evans, MD, a Contributing Editor with UroToday. |
|
UroToday, 1802 Fifth Street, Berkeley CA 94710 510.540.0930 (fax), info@urotoday.com ISSN 1939-4810
Privacy Policy | © 2009 UroToday ® All Rights Reserved |
